6th Annual World Life Sciences Conference
1 Jun - 2 Jun 2018
Session information
Committee(s)
Intellectual Property and Entertainment Law Committee
(Lead)
Life Sciences Subcommittee
(Lead)
Description
Gene-editing technologies, such as CRISPR-Cas9, are all the rage. But what are they? What are the potential benefits and risks? How are these technologies being regulated and commercialised? What are the patent issues? We will discuss these questions and more.
Session / Workshop Chair(s)
| Kevin Esvelt | MIT Media Lab, Cambridge, Massachusetts, USA |
| Alex Spiegler | Arent Fox Schiff LLP, New York, New York, USA |